First United Bank & Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.03K Hold
105
﹤0.01% 372
2026
Q1
$3.86K Hold
105
﹤0.01% 360
2025
Q4
$5.34K Hold
105
﹤0.01% 344
2025
Q3
$5.83K Hold
105
﹤0.01% 364
2025
Q2
$7.25K Hold
105
﹤0.01% 322
2025
Q1
$7.29K Hold
105
﹤0.01% 327
2024
Q4
$9.03K Hold
105
﹤0.01% 314
2024
Q3
$12.5K Hold
105
﹤0.01% 302
2024
Q2
$15K Hold
105
0.01% 307
2024
Q1
$13.5K Hold
105
0.01% 329
2023
Q4
$10.9K Buy
+105
New +$10.4K ﹤0.01% 341

Other funds holding NVO

First United Bank & Trust's NVO Position: Q2 2026 in Review

First United Bank & Trust held its Novo Nordisk (NVO) position steady in Q2 2026 at 105 shares worth $5.03K. The position accounts for ﹤0.01% of the portfolio, ranked #372.

First United Bank & Trust first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $15K in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • First United Bank & Trust held 105 shares of Novo Nordisk worth $5.03K as of Q2 2026.
  • First United Bank & Trust left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #372 holding.
  • First United Bank & Trust first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • First United Bank & Trust's Novo Nordisk position peaked at $15K in Q2 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.